Literature DB >> 11891388

The use of smallpox virus as a biological weapon: the vaccination situation in France.

D Lévy-Bruhl1, N Guérin.   

Abstract

In the context of its plan to fight against bioterrorism, the Ministry of Health asked the Institut de Veille Sanitaire to evaluate the epidemic risk from a release of the small pox virus, and to make recommendations on potential vaccination strategies to be implemented. A benefit/risk assessment of various vaccination scenarios, including vaccination of the whole French population, was carried out to evaluate the severity of a terrorist action threat. This analysis concludes that at this stage, vaccination action does not seem to be justified. Even in the case of a real threat, the vaccination of frontline healthcare personnel, and in particular of contacts of cases, must be given priority.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11891388     DOI: 10.2807/esm.06.11.00385-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  4 in total

1.  Interim smallpox guidelines for the United Kingdom.

Authors:  Richard Harling; Dilys Morgan; W John Edmunds; Helen Campbell
Journal:  BMJ       Date:  2002-12-14

2.  New generation of cell culture assay for smallpox vaccine potency.

Authors:  Isabelle Leparc-Goffart; Bertrand Poirier; Annie El Zaouk; Marie-Hélène Tissier; Florence Fuchs
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers.

Authors:  Philippe Bossi; Frédérick Gay; Imène Fouzai; Béhazine Combadière; Geneviève Brousse; Bénédicte Lebrun-Vignes; Jean-Marc Crance; Brigitte Autran; Daniel Garin
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

4.  Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.

Authors:  Qicheng Zhang; Meijuan Tian; Yi Feng; Kai Zhao; Jing Xu; Ying Liu; Yiming Shao
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.